Microbiota Accelerates Age-Related CpG Island Methylation in Colonic Mucosa
DNA methylation changes in aging cells and tissues | HSTalks
First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult
Jean-Pierre Issa - President and CEO - Coriell Institute for Medical Research | LinkedIn
Investigators and Staff
Dr. Jean-Pierre Issa, MD | Philadelphia, PA | Internal Medicine | Vitals
Press Releases
The Myelodysplastic Syndrome as an Epigenetic Disease”
Jean-pierre Issa, Professor - eMedEvents
Jean-Pierre Issa, MD, Philadelphia, PA | Oncologist
Pulling Back the Curtain: Allen Yang, MD, PhD
Spotlight On: Jean-Pierre Issa, President and CEO, Coriell Institute for Medical Research - Capital Analytics
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
Jean-Pierre Issa, MD, Philadelphia, PA | Oncologist
Coriell CEO Dr. Jean-Pierre Issa outlines his goals for the Camden Institute - Philadelphia Business Journal
Our Faculty | Jean-Pierre Issa | Coriell Institute
Epigenetic Therapies — New Approaches | TRP
Dr. Jean-Pierre Issa Details the Positive Impacts of Reducing Caloric Intake | Temple Health
Jean-Pierre Issa, MD, Coriell Institute for Medical Research, presents "Epigenetics in aging, cancer and cancer therapy"
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
NOVA | Ghost in Your Genes | Epigenetic Therapy | PBS
Dr. Jean-Pierre Issa, MD – Philadelphia, PA | Oncology
Hussein A. Abbas | MD Anderson Cancer Center
Interview with Dr. Jean-Pierre Issa | CancerQuest
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
Dr. Jean-Pierre Issa, MD - Oncology Specialist in Houston, TX | Healthgrades
Camden-based Coriell Institute hires Jean-Pierre Issa for CEO post - Philadelphia Business Journal
